DiviDrip · LXRX

LXRX — Lexicon Pharmaceuticals, Inc.

LXRX is Lexicon Pharmaceuticals, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.26. Market cap: $997M. Capital Quality Rank: 36/100 — Stagnant mediocrity.

Stock snapshot

Price$2.26
Market cap$997M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)36 / 100 · Stagnant mediocrity
ROIC (TTM)-31.6%
Shareholder buyback yield-11.85%
Altman Z-score zoneDistress

About LXRX

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Listed2000Employees81HQThe Woodlands, TXSectorHealthcareWebsitelexpharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside LXRX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is LXRX's current stock price?

LXRX (Lexicon Pharmaceuticals, Inc.) is currently trading at $2.26.

Does LXRX pay a dividend?

LXRX (Lexicon Pharmaceuticals, Inc.) does not currently pay a regular dividend.

What is LXRX's Capital Quality Rank?

LXRX has a Capital Quality Rank of 36/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track LXRX in DiviDrip

Add LXRX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow